CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q3 2018. The put-call ratio across all filers is 0.91 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $7,181,000 | +168.3% | 289,810 | +294.3% | 0.01% | +266.7% |
Q4 2021 | $2,676,000 | +1199.0% | 73,505 | +1726.2% | 0.00% | – |
Q1 2021 | $206,000 | -17.9% | 4,025 | -0.7% | 0.00% | – |
Q4 2020 | $251,000 | -1.2% | 4,054 | -12.5% | 0.00% | – |
Q3 2020 | $254,000 | +23.9% | 4,634 | +29.8% | 0.00% | – |
Q2 2020 | $205,000 | +34.9% | 3,570 | -78.2% | 0.00% | – |
Q2 2019 | $152,000 | -50.3% | 16,360 | -25.8% | 0.00% | -100.0% |
Q1 2019 | $306,000 | +123.4% | 22,040 | +112.3% | 0.00% | – |
Q2 2018 | $137,000 | – | 10,380 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |